{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:25Z","timestamp":1786119085019,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/grf.0b013e318180b8ed","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:00:11Z","timestamp":1236265211000},"page":"592-606","source":"Crossref","is-referenced-by-count":14,"title":["Breast Cancer and Hormonal Therapy"],"prefix":"10.1097","volume":"51","author":[{"given":"PETER","family":"CONNER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EVA","family":"LUNDSTR\u00d6M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BO","family":"VON SCHOULTZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210126","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","article-title":"Estrogen and the risk of breast cancer","volume":"344","author":"Clemons","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-15-20210126","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(05)66546-4","article-title":"Breast cancer","volume":"365","author":"Veronesi","year":"2005","journal-title":"Lancet"},{"key":"R3-15-20210126","first-page":"143","article-title":"Breast cancer and climacteric complaints: weighing up risks of hormone therapy against quality of life","volume":"134","author":"Franke","year":"2007","journal-title":"EJOG"},{"key":"R4-15-20210126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(02)09454-0","article-title":"Breast cancer and breast feeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women without the disease","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"R5-15-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02841869609098472","article-title":"Genetic predisposition to breast cancer","volume":"35","author":"Olsson","year":"1996","journal-title":"Acta Oncol"},{"key":"R6-15-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.maturitas.2004.06.013","article-title":"Hormones and mammographic breast density","volume":"49","author":"Warren","year":"2004","journal-title":"Maturitas"},{"key":"R7-15-20210126","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S1470-2045(05)70390-9","article-title":"Mammographic breast density as an intermediate phenotype for breast cancer","volume":"6","author":"Boyd","year":"2005","journal-title":"Lancet Oncol"},{"key":"R8-15-20210126","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/bjs.1800830805","article-title":"Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer","volume":"83","author":"Reid","year":"1996","journal-title":"Br J Surg"},{"key":"R9-15-20210126","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1158\/1078-0432.931s.11.2","article-title":"Breast differentiation and its implication in cancer prevention","volume":"11","author":"Russo","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R10-15-20210126","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/bcr1029","article-title":"The protective role of pregnancy in breast cancer","volume":"7","author":"Russo","year":"2005","journal-title":"Breast Cancer Res"},{"key":"R11-15-20210126","first-page":"7415","article-title":"Increased cell division as a cause of human cancer","volume":"50","author":"Preston-Martin","year":"1990","journal-title":"Cancer Res"},{"key":"R12-15-20210126","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/07853890601039842","article-title":"Breast response to menopausal hormone therapy-aspects on proliferation, apoptosis and mammographic density","volume":"39","author":"Conner","year":"2007","journal-title":"Ann Med"},{"key":"R13-15-20210126","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/bcr580","article-title":"Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast","volume":"5","author":"Shekhar","year":"2003","journal-title":"Breast Cancer Res"},{"key":"R14-15-20210126","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(98)00042-9","article-title":"Estradiol and progesterone regulate the proliferation of human breast epithelial cells","volume":"69","author":"Foidart","year":"1998","journal-title":"Fertil Steril"},{"key":"R15-15-20210126","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/019262301301418883","article-title":"Assessment of hormonally active agents in the reproductive tract of female nonhuman primates","volume":"29","author":"Cline","year":"2001","journal-title":"Toxicol Pathol"},{"key":"R16-15-20210126","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajog.2004.11.056","article-title":"Expression of p53 and markers for apoptosis in breast tissue during long-term hormone therapy in cynomolgus monkeys","volume":"193","author":"Conner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R17-15-20210126","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1365-2303.2003.00054.x","article-title":"Hormone receptor status in breast cancer--a comparison between surgical specimens and fine needle aspiration biopsies","volume":"14","author":"L\u00f6fgren","year":"2003","journal-title":"Cytopathology"},{"key":"R18-15-20210126","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006482418082","article-title":"Effects of oral contraceptives on breast epithelial proliferation","volume":"65","author":"Isaksson","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"R19-15-20210126","first-page":"4559","article-title":"Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast","volume":"84","author":"Hofseth","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-15-20210126","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9378(99)70560-0","article-title":"Mammographic breast density during hormone replacement therapy: differences according to treatment","volume":"181","author":"Lundstr\u00f6m","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R21-15-20210126","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.fertnstert.2005.09.026","article-title":"Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study","volume":"85","author":"Lundstrom","year":"2006","journal-title":"Fertil Steril"},{"issue":"1","key":"R22-15-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/09513590400030004","article-title":"Is mammographic density, as currently measured, a robust surrogate marker for breast cancer?","volume":"21","author":"Yaffe","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"R23-15-20210126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/13697130701385805","article-title":"Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density","volume":"10","author":"Lundstr\u00f6m","year":"2007","journal-title":"Climacteric"},{"key":"R24-15-20210126","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.GME.0000055522.67459.89","article-title":"A physiologic role for testosterone in limiting estrogenic stimulation of the breast","volume":"10","author":"Dimitrakakis","year":"2003","journal-title":"Menopause"},{"key":"R25-15-20210126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/01.gme.0000232033.92411.51","article-title":"Testosterone inhibits estrogen\/progestogen-induced breast cell proliferation in postmenopausal women","volume":"14","author":"Hofling","year":"2007","journal-title":"Menopause"},{"key":"R26-15-20210126","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/13697130701258812","article-title":"Tesosterone addition during menopausal hormone therapy: effects on mammographic breast density","volume":"10","author":"Hofling","year":"2007","journal-title":"Climacteric"},{"key":"R27-15-20210126","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"R28-15-20210126","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humupd\/dmi028","article-title":"Breast cancer risk with postmenopausal hormonal treatment","volume":"11","author":"Collins","year":"2005","journal-title":"Hum Reprod Update"},{"key":"R29-15-20210126","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1001\/jama.281.22.2091","article-title":"Hormone replacement therapy and risk of breast cancer with a favorable histology","volume":"281","author":"Gapstur","year":"1999","journal-title":"JAMA"},{"key":"R30-15-20210126","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1001\/jama.289.24.3254","article-title":"Relationship between long durations and different regimens of hormone therapy and risk of breast cancer","volume":"289","author":"Li","year":"2003b","journal-title":"JAMA"},{"key":"R31-15-20210126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"R32-15-20210126","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.287.6.734","article-title":"Hormone replacement therapy in relation to breast cancer","volume":"287","author":"Chen","year":"2002","journal-title":"JAMA"},{"key":"R33-15-20210126","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1020617415381","article-title":"Estrogen-progestin replacement therapy and breast cancer risk: the Women's Health Study (United States)","volume":"13","author":"Porch","year":"2002","journal-title":"Cancer Causes Control"},{"key":"R34-15-20210126","first-page":"1148","article-title":"Hormone replacement therapy regimens and breast cancer risk","volume":"100","author":"Weiss","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R35-15-20210126","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"R36-15-20210126","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/ijc.20016","article-title":"Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe","volume":"109","author":"Stahlberg","year":"2004b","journal-title":"Int J Cancer"},{"key":"R37-15-20210126","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","article-title":"Unopposed estrogen therapy and the risk of invasive breast cancer","volume":"166","author":"Chen","year":"2006","journal-title":"Arch Intern Med"},{"key":"R38-15-20210126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R39-15-20210126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1471-0528.2007.01520.x","article-title":"Hormone replacement therapy use and variations in the risk of breast cancer","volume":"115","author":"Opatrny","year":"2008","journal-title":"BJOG"},{"key":"R40-15-20210126","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"R41-15-20210126","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","article-title":"Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy","volume":"295","author":"Stefanick","year":"2006","journal-title":"JAMA"},{"key":"R42-15-20210126","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jama.288.1.58","article-title":"Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen\/progestin replacement study follow-up (HERS II)","volume":"288","author":"Hulley","year":"2002","journal-title":"JAMA"},{"key":"R43-15-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1055-9965.EPI-07-0558","article-title":"Relationship between menopausal hormone therapy and risk of ductal, lobular and ductal-lobular breast carcinomas","volume":"17","author":"Li","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R44-15-20210126","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Menopausal hormone therapy after breast cancer: the Stockholm randomized trial","volume":"97","author":"von Schoultz","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R45-15-20210126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS steering and data montoring committees. HABITS (hormonal replacement therapy after breast cancer-is it safe?), a randomised comparison: trial stopped","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"R46-15-20210126","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.AOG.0000163253.27610.b9","article-title":"Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator in postmenopausal women","volume":"105","author":"Ronkin","year":"2005","journal-title":"Obstet Gynecol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GRF.0b013e318180b8ed","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:44:00Z","timestamp":1786038240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003081-200809000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0b013e318180b8ed","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}